Prospective study comparing hepatic steatosis assessment by magnetic resonance imaging and four ultrasound methods in 105 successive patients

Table 1 Characteristics of the 105 patients, n (%)

Characteristics of the 105 patients
Demographic and anthropometric data
Sex (male)	51 (49)
Age (yr)	56 ± 14
BMI (kg/m2)	31 ± 6
Overweight	94 (90)
Obesity	50 (48)
Waist circumference (cm)1	107 ± 15
Diabetes	38 (36)
Hypertension	42 (40)
Metabolic syndrome	73 (70)
Biological data
Platelets count (G/L)1	231 ± 72
AST (U/L)1	35 ± 28
ALT (U/L)1	65 ± 49
GGT (U/L)1	120 ± 125
Triglycerides (g/L)1	1.7 ± 0.93
HDL cholesterol (g/L)1	1.3 ± 0.4
Ferritin (ng/mL)1	232 ± 283
Steatosis assessment
PDFF (%)1	15 ± 10
Steatosis on MRI	85 (81)
Fibroscan®
Technical success	104 (99)
cCAP (dB/m)	283 ± 58
Liver stiffness (KPa)1	8 ± 7
Liver stiffness > 10 KPa	21 (20)
Use of M probe	83 (80)
Use of XL probe	21 (20)
Aixplorer MACH 30®
Technical success	105 (100)
SSE (m/s)1	1519 ± 22
AC (dB/cm/MHz)1	0.48 ± 0.1
HRI1	1.43 ± 0.28
Technical success	104 (99)

¹Data are mean ± SD.

BMI: Body mass index; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; GGT: Gamma glutamyl transferase; PDFF: Proton density fat fraction; cCAP: Continuous controlled attenuation parameter; SSE: Sound speed estimation; AC: Attenuation coefficient; HRI: Hepato-renal index.